Shots: Novartis to receive $210M as total deal value, including $120M upfront, $60M deferred payment for 12mos. and $30M milestone on sales of product. Clinigen to get commercialization rights for […]readmore
Tags : Agreement
Shots: ITROM to get exclusive commercialization rights for Mithra’s Myring in MENA territories (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman, Lebanon, and Jordan) with a total deal value of $6.79M. […]readmore
Shots: Dermira to receive $30M upfront. Almira to get exclusive option to license rights for Dermira’s lebrikizumab to develop in dermatology & commercialize it in all indications in EU, with […]readmore
Shots: TeneoOne to receive $90M upfront and will take care of P-I trial for TNB-383B with its expected onset in H1’19. AbbVie to get exclusive WW rights to develop and […]readmore
Shots: Moberg to receive $1.69M upfront, $56.39M milestone, royalties & supply fees based on sales of MOB-015. Bayer to get exclusive commercialization rights for MOB-015 in EU post completion of […]readmore
Shots: Samsung Bioepis to receive upfront and royalties on sales of products from C-Bridge. C-Bridge to build a pharmaceutical firm AffaMed Therapeutics and further collaborate with Samsung for clinical development, […]readmore
Shots: Evotec to receive upfront, milestones and royalties on sales of product from Galapagos. Galapagos to get WW commercialization rights for developed product, will be responsible for future development and […]readmore
Shots: Ligand to receive upfront, milestones, and royalties for each of the product developed using OmniAb technology. Genagon to get WW rights for Ligand’s Omniab technology including the developed products […]readmore
Shots: Hisamitsu to receive upfront, milestone based on the regulatory approval and royalties on sales of product. Kyowa Kirin to get exclusive commercialization rights for Hisamitsu’s HP-3000, post marketing approval […]readmore
Shots: Xencor to receive $120M upfront, $160M milestones for XmAb24306 program and $180M for IL-15 candidate. Genentech to get worldwide commercialization rights for XmAb24306 & IL-15 program, with Xencor has […]readmore